Compare VOR & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | BFST |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2021 | 2014 |
| Metric | VOR | BFST |
|---|---|---|
| Price | $19.89 | $30.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | ★ $39.00 | $34.90 |
| AVG Volume (30 Days) | ★ 1.2M | 176.8K |
| Earning Date | 11-12-2026 | 10-26-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | N/A | ★ 23.45 |
| EPS | N/A | ★ 1.37 |
| Revenue | N/A | ★ $10,704,000.00 |
| Revenue This Year | N/A | $14.66 |
| Revenue Next Year | N/A | $7.04 |
| P/E Ratio | ★ N/A | $22.42 |
| Revenue Growth | N/A | ★ 1.20 |
| 52 Week Low | $6.50 | $22.56 |
| 52 Week High | $33.42 | $32.53 |
| Indicator | VOR | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 45.99 |
| Support Level | $17.10 | $29.49 |
| Resistance Level | $24.23 | $31.63 |
| Average True Range (ATR) | 1.37 | 0.46 |
| MACD | 0.06 | 0.02 |
| Stochastic Oscillator | 35.87 | 67.08 |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.